Cargando…
ProLung™-budesonide Inhibits SARS-CoV-2 Replication and Reduces Lung Inflammation
BACKGROUND: Inhaled budesonide benefits patients with COVID-19. ProLung™-budesonide enables the sustained, low dose administration of budesonide within a delivery vehicle similar to lung surfactant. ProLung™-budesonide may offer anti-inflammatory and protective effects to the lung in COVID-19, yet i...
Autores principales: | Konduri, Kameswari S., Pattisapu, Ram, Pattisapu, Jogi, Konduri, Girija G., Zwetchkenbaum, John, Roy, Bidhan, Barman, Monalisa, Frazier, Adria, Hurst, Brett L., Düzgüneş, Nejat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580381/ https://www.ncbi.nlm.nih.gov/pubmed/34766166 http://dx.doi.org/10.33696/pharmacol.3.028 |
Ejemplares similares
-
TSGA10 is Specifically Expressed in Astrocyte and Over-expressed in Brain Tumors
por: Behnam, Babak, et al.
Publicado: (2009) -
Expression of aquaporins in a transgenic mouse model of Alzheimer's disease
por: Chan, Sic L, et al.
Publicado: (2010) -
Evidence for reduced lymphatic CSF absorption in the H-Tx rat hydrocephalus model
por: Rammling, Matthias, et al.
Publicado: (2008) -
Decreased AMP‐activated protein kinase (AMPK) function and protective effect of metformin in neonatal rat pups exposed to hyperoxia lung injury
por: Yadav, Abha, et al.
Publicado: (2020) -
Caffeine Ameliorates Hyperoxia-Induced Lung Injury by Protecting GCH1 Function in Neonatal Rat Pups
por: Jing, Xigang, et al.
Publicado: (2017)